Curing acute lymphoblastic leukemia and avoiding osteonecrosis: can't we have it all?

Pediatr Blood Cancer. 2013 May;60(5):713-4. doi: 10.1002/pbc.24388. Epub 2013 Jan 17.

Authors

Stéphane Ducassou¹, Yves Pérel

Affiliation

¹ Unit of Pediatric Hematology and Oncology, Children's Hospital, Bordeaux University Hospital, Bordeaux, France.

PMID: 23335158
DOI: 10.1002/pbc.24388

No abstract available

Publication types

Comment

MeSH terms

Bone Density Conservation Agents / therapeutic use*
Diphosphonates / therapeutic use*
Female
Humans
Male
Osteonecrosis / drug therapy*
Pamidronate
Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*

Substances

Bone Density Conservation Agents
Diphosphonates
Pamidronate